Company / Operating Cash Flow
Vericel Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$51.9M
FY2025
5-year range
-$7.2M / $58.2M
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
#59 of 216
Health Care
What the data says
At $52M, Vericel's operating cash flow ranks #59 of 216 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from -$25M in FY2016 to $58M in FY2024.
Based on SEC 10-K filings.
$52M in FY2025 with a 3-year CAGR of +43.5%.
Improved from $35M to $52M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +43.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#59 of 216 in Health CareTop 27% of 216This company $51.9M Sector average $658.7M
▼
-92.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +43.5%, indicating consistent growth.
- In FY2025, operating cash flow decreased 10.8% year-over-year.
- Ranks #59 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.9M | -10.8% |
| FY2024 | $58.2M | +64.7% |
| FY2023 | $35.3M | +101.0% |
| FY2022 | $17.6M | +344.6% |
| FY2021 | -$7.2M | -1643.4% |
| FY2020 | -$412.0K | +96.9% |
| FY2019 | -$13.2M | +33.7% |
| FY2018 | -$19.9M | -49.0% |
| FY2017 | -$13.3M | +47.5% |
| FY2016 | -$25.4M | -27.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026